Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Vitamin D in Colon Cancer
NCT02172651Phase 1Recruiting
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jul 2014
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of vitamin d in colon cancer (3 arms), sponsored by Dana-Farber Cancer Institute. Primary endpoint: Vitamin D Receptor Binding Sites. Started Jul 2014; status: recruiting.
02
Drugs
vitamin d
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02172651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172651.